NCT06631092 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06631092
Title	Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	NEC Bio B.V
Indications	triple-receptor negative breast cancer
Therapies	NECVAX-NEO1
Age Groups:	senior \| adult
Covered Countries	DEU

Facility	Status	City	State	Zip	Country	Details
University Clinic Erlangen	RECRUITING	Erlangen			Germany	Details
National Center for Tumor Diseases Heidelberg	RECRUITING	Heidelberg			Germany	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06631092Clinical Trial Detail